Terns Pharmaceuticals
TERN
TERN
157 hedge funds and large institutions have $477M invested in Terns Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 67 increasing their positions, 33 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 155 → 157 (+2)
9% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 35
28% less capital invested
Capital invested by funds: $663M → $477M (-$186M)
Holders
157
Holding in Top 10
4
Calls
$3.69M
Puts
$869K
Top Buyers
| 1 | +$14.2M | |
| 2 | +$11.9M | |
| 3 | +$10.6M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$8.1M |
| 5 |
BlackRock
New York
|
+$5.79M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$12.9M | |
| 3 | -$9.08M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.06M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.86M |